Navigation Links
TPI Discusses Non-Cash Non-Operational Financial Impact from Warrants
Date:6/17/2011

CHENGDU, China, June 17, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI, the "Company"), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients (API) today discussed the non-cash, non-operational financial impact from the warrants issued in January 2008 under the ASC 815-40-15 (formerly EITF 07-05).

In the financial report of Third quarter fiscal year 2011 ending March 31, 2011, the Company has disclosed that under ASC 815-40-15, the Company's accounting treatment of the Series A and B warrants from July 1, 2009 until December 31, 2010 is subject to revisions. Due to the presence of certain anti-dilutive (down round protection) clauses in both warrants during the above period, these financial instruments have been re-categorized as liabilities while they were previously treated as equity.

On January 14, 2011, these anti-dilutive clauses in both series of warrants were removed therefore the warrants were re-categorized as equity in the third quarter of fiscal year 2011 while the accounting issues related to the warrants ceased to exist.

Based on the warrants' exercise data and weighted valuation, the Company has calculated the non-cash impact for the fiscal year 2010 and the first two quarters of fiscal year 2011. The analysis indicated that

  1. The non-cash impact from the warrants for fiscal year 2010 ending June 30, 2010 was a loss of ($0.16) million, or (1.07%) to pretax net income of $14.7 million
  2. The non-cash impact from the warrants for the first two quarters of fiscal year 2011 was a gain of $1.28 million, or 12.9% to net income for the first two quarters of fiscal year 2011 of $9.9 million.

Management and the Board of Directors of the Company discussed this matter with the Company's principal accountants and de
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
2. VHGI Discusses Recent Addition to the Regulation SHO Threshold Security Listing
3. Robotic Surgery Expert Dr. David B. Samadi, MD Discusses New Evidence That Proves The Low Complication Rates of Robotic Prostatectomy
4. With Over 3,000 Robotic Prostatectomy Surgeries to His Credit, Dr. David Samadi, MD Discusses SMART Surgery and How it Improves Sexual and Urinary Function
5. Prostate Cancer Treatment Expert Dr. David Samadi, MD Discusses Study Which Found That Low-Income Men Had High-Risk Prostate Cancer Tumors
6. Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone
7. Robotic Surgery Expert Dr. David Samadi, MD Discusses FDA Warnings on the Effect of GnRH Agonists
8. New York Robotic Surgery Expert Dr. David Samadi, MD Discusses New Findings that Hormone Therapy May Increase Risk of Developing Colorectal Cancer
9. Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Staging and Prostate Cancer Recurrence Study
10. Dr. David B. Samadi Discusses Why Robotic Surgery is Quickly Becoming the Go-To Standard for Prostate Cancer Treatment
11. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... MUMBAI , July 2, 2015 ... equity stake in ZAO "Biocom" in Russia ... foray into the Russian pharmaceutical market which recorded RUB 765 ... 10 pharmaceutical markets in the world in 2014 (IMS Health). ... growth and expected to continue with this trend, projecting ...
(Date:7/2/2015)... 2, 2015 The report "Silage ... Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), ... 2020", Silage Inoculants & Enzymes Market is expected to ... 4.0% from 2015 to 2020. Browse ... through 194 P ages and an ...
(Date:7/2/2015)... 2015 BGI gab heute bekannt, ... vom American College of Pathologists (CAP) akkreditiert ... erste klinische Next-Generation-Sequencing Labor, das in ... und somit die höchsten Standards an klinischer ... FDA - 21 CFR Part 11 konformen ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
... BROWNE, MORGAN FREEMAN, SAMUEL L. JACKSON, GEORGE LOPEZ, ... Oct. 24 On Thursday, November 15, 2007,Artists for a ... benefit, at The Wiltern in Los Angeles. The evening combines,the ... -- from the personal,to the global -- and make a ...
... Support Preclinical Development of Intradigm,s ICS-283, ... Corporation, a,leading developer of targeted, systemic RNA ... demonstrated the company,s,TargeTran(TM) delivery system is capable ... small interfering RNAs (siRNAs) that suppress,tumor-induced angiogenesis ...
Cached Medicine Technology:Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles 2Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles 3Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice 2Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice 3
(Date:7/2/2015)... ... July 02, 2015 , ... Real Time Pain Relief (RTPR), makers of the popular ... Big Sky PBR to sponsor The Fifth Annual Big Sky Professional Bull Riders Event ... product samples of their popular pain relief lotion and products at the family friendly event ...
(Date:7/2/2015)... ... 02, 2015 , ... Five individuals from Loma Linda University ... specialized disaster training. The team – composed of four clinicians and one administrative ... who attended the training, which is dedicated to preparing first responders for a ...
(Date:7/2/2015)... Kan. (PRWEB) , ... July 02, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... of the top executive search firms in the healthcare industry, B. E. Smith ...
(Date:7/2/2015)... ... July 02, 2015 , ... AvePoint Public Sector, Inc., ... across platforms and devices, today announced it was named the recipient of the 2015 ... The award, given out by the Government Technology Research Alliance (GTRA), was presented June ...
(Date:7/2/2015)... ... July 02, 2015 , ... As the world becomes more connected through the ... interact with products in their everyday lives. Technology can now help homeowners gain more ... entertainment and safety, as well as making kitchen tasks simpler. , "Summer ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 2Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 3Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 2Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 3Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4
... at the University of Pennsylvania,s Abramson Cancer Center have ... activating the immune system to destroy the cancer,s scaffolding. ... patients with advanced pancreatic cancer, several of whose tumors ... the novel way in which they uncovered them -- ...
... , THURSDAY, March 24 (HealthDay News) -- Researchers ... shrink pancreatic tumors by targeting the tissue surrounding cancer ... on an experimental antibody that sparks the patient,s own ... tumors together. Although testing has so far been ...
... books contain messages about health, but 24.6% of these are ... by the Knowledge Management Unit at Baza Hospital (Granada), published ... of 844 health messages in primary and secondary school text ... underpinning these texts, and we classified them into three categories ...
... MRC Lifecourse Epidemiology Unit in Southampton, UK, have presented ... falls history, in addition to clinical risk factors (CRFs) ... the accuracy of fracture prediction models. The research findings ... & Osteoarthritis in Valencia, Spain. Using results from ...
... acupuncture - sometimes referred to as placebo - is ... in cancer patients undergoing radiotherapy, according to a study ... who received only standard care including medications for nausea, ... acupuncture groups. "The beneficial effects seem not to ...
... Research fellow at the Centre for Bone Research at ... Zanchetta, Research fellow at the Instituto de Investigaciones Metablicas ... of the 2011 ESCEO-AMGEN Fellowship. Awarded by ... Osteoporosis and Osteoarthritis (ESCEO) with support from Amgen, the ...
Cached Medicine News:Health News:Penn researchers uncover novel immune therapy for pancreatic cancer 2Health News:Penn researchers uncover novel immune therapy for pancreatic cancer 3Health News:Novel Treatment for Pancreatic Cancer Under Study 2Health News:Novel Treatment for Pancreatic Cancer Under Study 3Health News:Around 25 percent of health messages in Spanish text books are not based on scientific evidence 2Health News:Acupuncture is equally effective with simulated needles 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: